Drug and supplement enforcement actions from the FDA, plus recalls for cosmetics and personal-care products. Data comes straight from official CPSC, FDA and USDA feeds and refreshes every six hours.
A free weekly email with new health & cosmetics recalls — nothing else. Unsubscribe anytime.
Recommended reading: What to do if your product is recalled
The recalled sweaters violate the mandatory standard for clothing textiles, posing a risk of serious burn injuries or death.
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
The heating element can remain energized during a ground fault, despite being turned off, posing a risk of fire or burn injury to consumers.
Product Contamination. WASHINGTON, June 25, 2026 – The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert for ready-to-eat chicken Caesar wrap products due to concerns that the product may be contaminated with Listeria monocytogenes ( Lm ). A recall was not requested because the products are no longer available for purchase. The ready-to-eat chicken Caesar wrap it
Potential contamination with Salmonella
Lack of Sterility Assurance
Lack of Sterility Assurance
Lack of Sterility Assurance
Lack of Sterility Assurance
Failed Impurities/Degradation Specifications
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
The recalled toys violate the small parts ban because they are intended for children under three and the small pacifier poses a deadly choking hazard to young children. In addition, the eyes on the plush bear can detach, also posing a choking hazard.
Dietary supplement product Vista MAX contains undeclared Yellow#5.
Dietary supplement product Ocular Plus contains undeclared Yellow#5.
Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
Subpotent Drug
CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.
Crystallization; identified as Buprenorphine free base
Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification.
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Lack of assurance of Sterility:
Lack of Assurance of Sterility
Subpotent Drug
Lack of Assurance of Sterility
Failed Impurities/Degradation Specifications
Failed Dissolution Specifications
The recalled tents' fiberglass poles can shed fibers, posing an injury risk of skin and eye irritation.
Presence of Foreign Substance
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Presence of Foreign Substance.
Presence of Foreign Substance.
CGMP Deviations
sub potency
CGMP Deviations
CGMP Deviations